Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Methadone and the heart: what the clinician needs to know.

George S, Moreira K, Fapohunda M.

Curr Drug Abuse Rev. 2008 Nov;1(3):297-302. Review.

PMID:
19630728
2.

QTc prolongation and torsades de pointes associated with methadone therapy.

Routhier DD, Katz KD, Brooks DE.

J Emerg Med. 2007 Apr;32(3):275-8. Epub 2007 Feb 2.

PMID:
17394991
3.

Torsades de pointes with methadone.

[No authors listed]

Prescrire Int. 2005 Apr;14(76):61-2.

PMID:
15875343
4.

QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system.

Pearson EC, Woosley RL.

Pharmacoepidemiol Drug Saf. 2005 Nov;14(11):747-53.

PMID:
15918160
5.

Methadone and affairs of the heart and of the brain.

Stimmel B.

J Addict Dis. 2003;22(3):1-5. No abstract available.

PMID:
14621340
6.

[Routine ECG in methadone-assisted rehabilitation is wrong prioritization].

Krook AL, Waal H, Hansteen V.

Tidsskr Nor Laegeforen. 2004 Nov 18;124(22):2940-1. Norwegian.

7.

Methadone-associated Q-T interval prolongation and torsades de pointes.

Stringer J, Welsh C, Tommasello A.

Am J Health Syst Pharm. 2009 May 1;66(9):825-33. doi: 10.2146/ajhp070392. Review. Erratum in: Am J Health Syst Pharm. 2010 Jan 15;67(2):94.

PMID:
19386945
8.

[Methadone-induced heart arrhythmia].

Østvold C, Topper M.

Tidsskr Nor Laegeforen. 2005 Aug 11;125(15):2021-2. Norwegian.

9.

Methadone-associated QT prolongation and torsades de pointes.

George S.

Br J Hosp Med (Lond). 2007 Apr;68(4):221. No abstract available.

PMID:
17465110
10.

Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?

Mayet S, Gossop M, Lintzeris N, Markides V, Strang J.

Drug Alcohol Rev. 2011 Jul;30(4):388-96. doi: 10.1111/j.1465-3362.2010.00237.x. Epub 2010 Sep 6.

PMID:
21355918
11.

Prolonged QT interval and methadone: implications for palliative care.

Wilcock A, Beattie JM.

Curr Opin Support Palliat Care. 2009 Dec;3(4):252-7. doi: 10.1097/SPC.0b013e328332e0a4. Review.

PMID:
19797957
12.

Does electrocardiography improve methadone safety?

Byrne A, Hallinan R, Newman RG.

Am J Health Syst Pharm. 2010 Jun 15;67(12):968-9. doi: 10.2146/ajhp100062. No abstract available.

PMID:
20516464
13.

QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France.

Perrin-Terrin A, Pathak A, Lapeyre-Mestre M.

Fundam Clin Pharmacol. 2011 Aug;25(4):503-10. doi: 10.1111/j.1472-8206.2010.00871.x. Epub 2010 Sep 6.

PMID:
20825488
14.

Methadone-induced long QT syndrome vs methadone-induced torsades de pointes.

Justo D.

Arch Intern Med. 2006 Nov 13;166(20):2288; author reply 2289-90. No abstract available.

PMID:
17101953
15.
16.

Methadone-associated QT prolongation and torsades de pointes. Dubrey and Groscott-Mason's patient was underttreated for her atrial fibrillation.

Al-Sardar H.

Br J Hosp Med (Lond). 2007 Apr;68(4):221; author reply 221. No abstract available.

PMID:
17469230
17.

Ciprofloxacin-induced torsades de pointes in a methadone-dependent patient.

Nair MK, Patel K, Starer PJ.

Addiction. 2008 Dec;103(12):2062-4. doi: 10.1111/j.1360-0443.2008.02390.x.

PMID:
19469750
18.

Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations.

Stallvik M, Nordstrand B, Kristensen Ø, Bathen J, Skogvoll E, Spigset O.

Drug Alcohol Depend. 2013 Apr 1;129(1-2):88-93. doi: 10.1016/j.drugalcdep.2012.09.016. Epub 2012 Oct 16.

PMID:
23084592
19.

Methadone and torsade de pointes: case report and review of the literature.

Iskandar SB, Abi-Saleh BS, Mechleb BK, Fahrig SA.

Tenn Med. 2007 Feb;100(2):35-7, 42. Review.

PMID:
17378505
20.

Onsite QTc interval screening for patients in methadone maintenance treatment.

Fareed A, Vayalapalli S, Byrd-Sellers J, Casarella J, Drexler K, Amar R, Smith-Cox J, Lutchman TS.

J Addict Dis. 2010 Jan;29(1):15-22. doi: 10.1080/10550880903436044.

PMID:
20390695

Supplemental Content

Support Center